SPDR S&P Biotech ETF $XBI Stock Sold by Means Investment CO. Inc.

Means Investment CO. Inc. decreased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 65.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,822 shares of the exchange traded fund’s stock after selling 11,012 shares during the quarter. Means Investment CO. Inc.’s holdings in SPDR S&P Biotech ETF were worth $918,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Bank of America Corp DE increased its position in shares of SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in SPDR S&P Biotech ETF by 145.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after buying an additional 186,314 shares during the period. Annex Advisory Services LLC lifted its position in SPDR S&P Biotech ETF by 4.6% in the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after buying an additional 11,723 shares during the last quarter. Moss Adams Wealth Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at about $30,841,000. Finally, Sivik Global Healthcare LLC lifted its position in SPDR S&P Biotech ETF by 20.0% in the third quarter. Sivik Global Healthcare LLC now owns 180,000 shares of the exchange traded fund’s stock valued at $28,382,000 after buying an additional 30,000 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $152.21 on Monday. The firm has a market cap of $10.41 billion, a PE ratio of 11.47 and a beta of 0.87. The company has a 50-day moving average of $155.22 and a two-hundred day moving average of $142.29. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.